Hostname: page-component-788cddb947-w95db Total loading time: 0 Render date: 2024-10-15T17:15:54.909Z Has data issue: false hasContentIssue false

233 Uganda-based Survey of Challenges in Breast Cancer Detection in Low and Middle Income Countries

Published online by Cambridge University Press:  24 April 2023

Krishna Tejaswini Sathi
Affiliation:
Johns Hopkins Center for Bioengineering Innovation and Design, Baltimore, MD, United States
Kim Hwang Yeo
Affiliation:
Johns Hopkins Center for Bioengineering Innovation and Design, Baltimore, MD, United States
Pav Naicker
Affiliation:
Johns Hopkins Center for Bioengineering Innovation and Design, Baltimore, MD, United States
Leanne Pichay
Affiliation:
Johns Hopkins Center for Bioengineering Innovation and Design, Baltimore, MD, United States
Antony Fuleihan
Affiliation:
Johns Hopkins Center for Bioengineering Innovation and Design, Baltimore, MD, United States
Peter Waiswa
Affiliation:
Makerere University School of Public Health, Kampala, Uganda
Youseph Yazdi
Affiliation:
Johns Hopkins Center for Bioengineering Innovation and Design, Baltimore, MD, United States
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

OBJECTIVES/GOALS: Low and middle income countries (LMICs) face challenges in early detection of breast cancer resulting in high breast cancer mortality. This study serves to identify gaps and opportunities for innovators seeking to address problems in early detection of breast cancer in Uganda and other LMICs. METHODS/STUDY POPULATION: Two methods were used: 1) Three weeks of ethnographic research in Uganda through primary stakeholder interviews and clinical observations. Interviews were conducted with patients, clinicians, NGOs, and key opinion leaders from the Uganda Cancer Institute, Makerere University, and JHPIEGO. Clinical observations were performed to note the workflow and availability of resources across diverse health centers ranging from village health teams in rural settings to the national referral hospital in the urban center. 2) A targeted literature search focused on breast cancer detection in LMICs. Keywords included breast cancer’, screening’, and diagnosis’. Identified challenges were validated through stakeholder interviews and categorized. Potential solutions to each challenge were explored. RESULTS/ANTICIPATED RESULTS: Three broad categories of challenges and suggested innovation targets were identified. 1) Ineffective clinical processes: deskilling and improving training around the process of clinical breast examinations, imaging operation and interpretation, and pathology preparation and interpretation; 2) Accessibility: increasing screening throughput, improving rural community access to breast cancer care, and increasing opportunistic screening; 3) Sensitization: increasing patient and health worker awareness of clinical presentations of breast cancer, reducing cultural barriers, and improving trust in the medical community. DISCUSSION/SIGNIFICANCE: Innovators seeking to solve problems in early breast cancer detection in LMICs should focus on ineffective clinical processes, accessibility, and sensitization. In conjunction with prompt treatment, there is potential to reduce breast cancer mortality rates in line with the Global Breast Initiative.

Type
Health Equity and Community Engagement
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - ND
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
Copyright
© The Author(s), 2023. The Association for Clinical and Translational Science